How to build a closing deliverables checklist for SAFE Financing Transactions

Build a company-side SAFE closing checklist by translating the agreed instruments, corporate approvals, and offering requirements into evidence-based deliverables for each investor. Separate signing, company acceptance, and funding; distinguish actual closing conditions from internal controls and post-closing obligations. Give every item a source, owner, completion standard, and disposition. The resulting checklist should show which investments are ready for a closing decision, which require further evidence or approval, and which obligations must pass to a named owner—without importing an unsupported priced-equity closing package.

When to use this workflow

Use this workflow when company counsel or an in-house legal team has substantially agreed SAFE terms and needs to coordinate approvals, signatures, payment, and closing records. For rolling closings, maintain investor-specific milestones alongside shared authorization and offering-level tasks.

The scope is initial SAFE issuance, not conversion into equity. This general workflow assumes a US offering and, for corporate authorization, a Delaware corporation. Other formation jurisdictions, state securities requirements, and negotiated governing law require separate analysis. Closing readiness depends on the actual instruments, applicable law, and facts—not a checklist completion percentage.

What you need

Collect the proposed closing set before assigning completion dates:

• Operative instruments: Each SAFE, identified form version, amendment, side letter, investor schedule, and related subscription or acceptance document.
• Authority records: Charter documents, board approvals, relevant delegations, and identified stockholder or contractual consents.
• Capitalization evidence: Current capitalization records, outstanding SAFEs and notes, option commitments, and existing investor rights relevant to approval scope or issuance restrictions.
• Offering analysis: The proposed exemption, investor documentation appropriate to that exemption, commitment-date evidence, and federal and state filing analysis.
• Payment records: Approved payment instructions, remittance information, and finance’s receipt-confirmation process.
• Release instructions: Legal names, signatory capacities, acceptance mechanics, document-release authority, and the company’s closing decision-maker.

Give documents stable IDs. Preserve superseded versions but identify them clearly. Ask the company custodian to distinguish an unavailable side letter from confirmation that none exists.

Use the template

The companion template is SAFE Financing Transactions — Closing deliverables checklist. You can copy this table into your working document or spreadsheet. Use one row per independently verifiable deliverable; repeat investor-specific items rather than treating the entire financing as one closing.

Source / citation identifies the document ID and section, page, or approval paragraph. Cite a company closing protocol for an internal control rather than inventing a contractual requirement.

Class / trigger distinguishes an express condition, covenant, representation, applicable legal prerequisite, or internal recommendation. Identify the relevant event and, for a condition, its beneficiary.

Completion evidence defines what proves satisfaction. Status / decision records open, satisfied, disputed, or deferred status, including the decision-maker and rationale. Handoff identifies a surviving obligation and its receiving owner. Keep sensitive payment details and lengthy supporting analysis in restricted linked records.

Step by step

1. Define the closing unit and confirm the document set

Identify whether the checklist covers one investor, a coordinated group, or successive acceptances. Assign investor IDs and a closing-set version. Match each SAFE to its amendments and side letters, including documents negotiated outside the principal email thread.

Reconcile purchase amounts, cap or discount terms, and form versions against the agreed terms. Preserve the actual capitalization definitions. YC explains that its post-money valuation cap is measured after SAFE money but before new money in the priced round; that explanation does not establish another form’s economics. See the YC Post-Money SAFE User Guide. (bookface-static.ycombinator.com)

Record: A document-set confirmation row for each investor, linking the agreed instruments and identifying unresolved discrepancies.

2. Classify requirements before treating them as blockers

Read payment, execution, issuance, and acceptance language together. Identify actual conditions and their beneficiaries. Separate promises, factual representations, and internal controls from conditions to closing.

For each unresolved condition, specify satisfaction evidence and ask counsel whether waiver is available and who can give it. Do not assume an officer can waive an investor protection or that party agreement can dispense with a legal prerequisite.

Keep future conversion documents outside the initial issuance checklist unless the present transaction independently requires them. A conversion-stage signature obligation does not, by itself, establish a current deliverable.

Record: Classification, exact source, beneficiary where relevant, and required satisfaction or counsel-confirmed waiver evidence.

3. Verify corporate and contractual authority

Compare the issuance against the approval package: instrument form, aggregate amount, investor coverage, consideration, signatories, and permitted changes. Check remaining approval capacity before accepting additional investors in a rolling financing. Investigate whether negotiated side-letter rights exceed that authority.

For Delaware corporations, DGCL §157 addresses rights or options to acquire stock, subject to the charter, and prescribes authorization and terms requirements. Counsel must determine its application to the particular SAFE; it does not alone resolve every charter, statutory, or contractual approval question. See Delaware Code, Title 8, §157. (delcode.delaware.gov)

Review identified debt and material-contract restrictions for consents potentially triggered by SAFE issuance. Distinguish those from restrictions implicated only by conversion or exit.

Record: Approval and consent rows identifying coverage, available capacity, unresolved scope questions, and required evidence.

4. Reconcile signatures, acceptance, and payment

Maintain distinct rows for investor signature, company signature or acceptance, and funding. Check names, capacities, blanks, dates, purchase amounts, and signature-page versions. Resolve post-signature changes before release rather than attaching an old signature page to a changed instrument without authorization.

Have finance confirm receipt and allocation to the correct investor and SAFE. Remittance advice alone does not establish receipt. Investigate shortfalls, duplicate transfers, and funds sent by a different entity; record counsel’s disposition rather than assuming their effect.

Verify payment instructions through an established channel as a company control. Keep banking details outside the broadly circulated checklist.

Record: Separate execution, acceptance, instruction-verification, and receipt statuses, with evidence and discrepancy resolutions.

5. Resolve side letters and investor-specific documents

Confirm that every agreed side letter is included, approved, and executed as required. Compare investor names and defined terms with the linked SAFE. Identify information, participation, and MFN provisions requiring administration after closing.

YC’s optional pro rata side letter addresses participation in the equity financing where its SAFE converts. Do not apply that trigger to differently negotiated participation rights; read the operative language. See the YC guide’s side-letter discussion. (bookface-static.ycombinator.com)

Check investor schedules and exemption-related documentation against counsel’s offering analysis. Record missing evidence without asserting that an unproduced document never existed.

Record: Each investor-specific deliverable, approval disposition, and surviving obligation’s source, trigger, and future owner.

6. Determine filing triggers before making the closing decision

Ask securities counsel to confirm the exemption and supporting evidence. SEC guidance requires Form D for offerings under Rule 504, Rule 506, or Securities Act §4(a)(5), within 15 days after the first investor becomes irrevocably contractually committed. A weekend or holiday due date moves to the next business day. This is not a universal SAFE deadline. See SEC, Filing a Form D Notice. (sec.gov)

Do not substitute the wire date for the contractual-commitment analysis or wait for the last investor before investigating the trigger. The SEC measures the deadline from the offering’s first sale, using that commitment standard. Record counsel’s supporting chronology and assign state notice analysis separately. SEC filing guidance. (sec.gov)

Record: Filing applicability, commitment evidence, deadline calculation, filing owner, and any unresolved question requiring immediate escalation.

7. Complete the evidence record and transfer surviving tasks

Review open rows with the authorized decision-maker. Mark an item satisfied only when its specified evidence exists. For a deferral, record why closing may proceed, who approved that conclusion, and who accepted the follow-up. Do not convert an unsatisfied condition into a routine administrative task by changing its status label.

Assemble final signed documents, approvals, receipt evidence, and the investor-specific closing determination. Reconcile the SAFE register and capitalization records to instruments actually issued; do not record initial SAFE issuance as issuance of conversion shares.

Record: Each investor’s closing disposition and accepted handoffs for filings, record updates, and continuing rights. Link later completion evidence to the same item IDs.

Worked example

Fictional scenario: Juniper Lantern, Inc., a Delaware corporation, proposes post-money SAFEs of $300,000 from Alder Path Ventures and $200,000 from Rowan Field Partners. All parties, documents, amounts, and clauses in this example are fictional.

Board consent AP-01 approves up to $500,000 using attached form SF-01. Paragraph 3 requires additional board approval before granting side-letter rights. Alder’s A-01 is signed by both parties; finance confirms receipt. Its §1 identifies the $300,000 purchase amount. Rowan has signed R-01, but the company has not accepted it; proposed information-rights letter SL-R remains unsigned. Counsel has identified Rule 506 as the intended exemption but has not completed the first-commitment analysis.

Alder’s receipt evidence completes only its payment-control row. It does not establish that every issuance requirement is satisfied. Rowan’s issue requires an authorization decision, not merely signature chasing. Counsel could seek approval or negotiate removal of the proposed rights, but neither outcome is assumed.

The offering-level filing question remains urgent regardless of Rowan’s delay. These distinctions permit separate investor decisions without allowing one investor’s administrative status to obscure a shared filing trigger or override another investor’s approval issue.

Common mistakes

• Copying a priced-round checklist. Remove preferred-stock and conversion documents unless a present requirement supports them.
• Using “signed” to mean “closed.” Track acceptance and funding separately, then apply the actual release mechanics.
• Calling every open task waivable. Classify the requirement and establish waiver availability and authority first.
• Ignoring cumulative approval limits. Reconcile accepted investments against available authority before each rolling acceptance.
• Losing side-letter obligations. Link rights to their SAFE and assign their actual triggers to an accountable owner.
• Starting filing analysis with each wire. Maintain an offering-level commitment chronology and escalate uncertainty promptly.

Final quality check

• Each investor matches the correct final SAFE, amendments, and side letters.
• Requirements have verified source citations; internal controls are labeled separately.
• Approval evidence covers the actual rights, instruments, and aggregate amount.
• Signing, acceptance, and funding have separate evidence and dispositions.
• Conditions are satisfied or addressed through documented, counsel-confirmed authority.
• Filing applicability, triggers, and deadline calculations have supporting records and owners.
• Every open issue is resolved or expressly assigned; deferrals explain why closing may proceed.
• Final evidence and accepted handoffs are linked by stable item IDs.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its contract review capabilities can support review of SAFEs and side letters, while tabular review supports work across documents. In Word, counsel can choose the represented party, supply deal-specific instructions, and assess findings that quote and locate clauses, rank severity, and identify missing language as not present. The checklist remains counsel’s work product, and lawyers retain authorization and closing decisions. To discuss this transactional workflow, book a demo.

Frequently asked questions

Does every SAFE investor need a separate checklist?

No. Use investor-specific rows in one checklist, linked to shared approvals and offering-level tasks. Preserve separate closing dispositions so one status does not conceal different signature or funding positions.

Can the company close before funds arrive?

Determine that from the payment, acceptance, and release provisions. Record counsel’s conclusion and any authorized funding arrangement rather than assuming signatures alone complete—or cannot complete—the issuance.

Should conversion-share documents appear here?

Include them only if relevant to a present requirement or authorization issue. Assign future conversion work separately rather than expanding initial issuance into a hypothetical priced-round closing.

What proves an item is complete?

Use the evidence specified for that row: adopted approval, final executed document, confirmed receipt, or documented legal determination. An email saying “handled” should link to the underlying record, not replace it.

Sources

• Delaware Code, Title 8, §157 — Rights and options respecting stock; applicability requires instrument-specific analysis.
• SEC, Filing a Form D Notice — Covered offering categories, first-sale standard, and notice timing.
• Y Combinator, Post-Money SAFE User Guide — Developer explanation of its SAFE and optional side letter, not legal authority.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.